Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor

Molecular Pharmacology

Volumn 56, Issue 3, 1999, Pages 657-663

  Sarau, Henry M ^b   Ames, Robert S ^b   Chambers, Jon ^b   Ellis, Catherine ^b   Elshourbagy, Nabil ^b   Foley, James J ^b   Schmidt, Dulcie B ^b   Muccitelli, Roseanna M ^b   Jenkins, Owen ^b   Murdock, Paul R ^b   Herrity, Nicole C ^b   Halsey, Wendy ^b   Sathe, Ganesh ^b   Muir, Alison I ^b   Nuthulaganti, Parvathi ^b   Dytko, George M ^b   Buckley, Peter T ^b   Wilson, Shelagh ^b   Bergsma, Derk J ^b   Hay, Douglas W P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PEPTIDOLEUKOTRIENE; PERTUSSIS TOXIN; PRANLUKAST; TRITIUM; ZAFIRLUKAST;

ARTICLE; BRONCHUS; CALCIUM TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CELL; LEUKOCYTE; LUNG; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 0032817289     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.3.657     Document Type: Article

References (32)

1. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril CR, Wu A, Olde B, Moreno RF, Kerlavage AR, McCombie WH and Venter JC (1991) Complementary DNA sequencing: Expressed sequence tags and human genome project. Science (Wash DC) 262:1651-1656.
2. Aiyar N, Baker E, Wu HL, Nambi P, Edwards RM, Trill JJ, Ellis C and Bergsma DJ (1994) Human AT1 receptor is a single copy gene: Characterization in a stable cell line. Mol Cell Biochem 131:75-86.
3. Borgeat B and Samuelsson B (1979) Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid. J Biol Chem 254:2643-2646.
4. Brocklehurst WE (1960) The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol 151:416-435.
5. Coleman RA, Eglen RM, Jones RL, Narumiya S, Shimizu T, Smith WL, Dahlen S, Drazen JM, Gardiner PJ, Jackson WT, Jones TR, Krell RD and Nicosia S (1995) Proatanoid and leukotriene receptors: A progress report from the IUPHAR working parties on classification and nomenclature. Adv Prostaglandin Thromboxane Leukot Res 23:283-285.
6. Corey EJ, Clark DA, Goto G, Marfat A, Mioskowski C, Samuelsson B and Hammarström S (1980) Stereospecific total synthesis of a "slow-reacting substance of anaphylaxis" (SRS-A), leukotriene C-1. J Am Chem Soc 102:1436-1439.
7. 4 receptor. Adv Prostaglandin Thromboxane Leukot Res 20:127-137.
8. Drazen JM and Austen KF (1987) Leukotrienes and airway responses. Am Rev Respir Dis 138:985-998.
9. Gorenne I, Norel X and Brink C (1996) Cysteinyl leukotriene receptors in the human lung: What's new? Trends Pharmacol Sci 17:342-345.
10. Hay DWP, Muccitelli RM, Tucker SS, Vickery-Clark LM, Wilson KA, Gleason JG, Hall RF, Wasserman MA and Torphy TJ (1987) Pharmacologic profile of SK&F 104353: A novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. J Pharmacol Exp Ther 243:474-481.
11. Hay DWP, Torphy TJ and Undem BJ (1995) Cysteinyl leukotrienes in asthma: Old mediators up to new tricks. Trends Pharmacol Sci 16:304-309.
12. Horwitz RJ, McGill KA and Busse WW (1998) The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med 157:1363-1371.
13. 4 receptor antagonist. Can J Physiol Pharmacol 73:191-201.
14. Kellaway CH and Trethewie ER (1940) The liberation of a slow-reacting smooth muscle-stimulating substance in anaphylaxis. Q J Exp Physiol Cogn Med Sci 30:121-145.
15. Krell RD, Aharony D, Buckner CK, Keith RA, Kusner EJ, Snyder DW, Bernstein PR, Matassa VG, Yee YK, Brown FJ, Hesp B and Giles RE (1990) The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist. Am Rev Respir Dis 141:978-987.
16. Labat C, Ortiz JL, Norel X, Gorenne I, Verly J, Abram TS, Cuthbert NJ, Tudhope SR, Norman F, Gardiner P and Brink C (1992) A second cysteinyl leukotriene receptor in human lung. J Pharmacol Exp Ther 263:800-805.
17. 1 receptor. Nature (Lond) 399:789-793.
18. Metters KM (1995) Leukotriene receptors. J Lipid Mediat Cell Signal 1:413-427.
19. 4 receptors in sheep tracheal smooth muscle. Mol Pharmacol 34:590-596.
20. Muccitelli RM, Tucker SS, Hay DWP, Torphy TJ and Wasserman MA (1987) Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison on leukotriene-, methacholine-, histamine-and antigen-induced contractions. J Pharmacol Exp Ther 243:467-473.
21. Murphy RC, Hammarström S and Samuelsson B (1979) Leukotriene C: A slow reacting substance from murine mastrocytoma cells. Proc Nalt Acad Sci USA 76:4275-4279.
22. Obata T, Okada Y, Motoishi M, Nakagawa N, Terawaki T and Aishita H (1992) In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues. Jpn J Pharmacol 60:227-237.
23. 4 on human airways smooth muscle cell proliferation, matrix expression and contraction in vitro: Differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 19:453-461.
24. Powell WS, MacLeod RJ, Gravel S, Gravelle F and Bhakar A (1996) Metabolism and biological effects of 5-eicosanoids on human neutrophils. J Immunol 156:336-342.
25. 4) receptor antagonist, in patients with chronic asthma. J Allergy Clin Immunol 98:528-534.
26. Samuelsson B (1983) Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science (Wash) 220:568-575.
27. 4 receptors in differentiated U-937 cells. J Biol Chem 264:19845-19855.
28. Schroeder KS and Neagle BD (1996) FLIPR: A new instrument for accurate, high throughput optical screening. J Biomolecular Screening 1:75-80.
29. 4 receptor antagonist, in subjects with bronchial asthma. Am J Respir Crit Care Med 150:618-623.
30. Stadel JM, Wilson S and Bergsma DJ (1997) Orphan G protein-coupled receptors: A neglected opportunity for pioneer drug discovery. Trends Pharmacol Sci 18:430-437.
31. Tamaoki J, Kondo M, Sakai N, Nakata J, Takemura H, Nagai A, Takizawa T and Konno K (1997) Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am J Respir Crit Care Med 155: 1235-1240.
32. 4 that mediates chemotaxis. Nature (Lond) 387:620-624.